Early Detection Research Network

Lung

LAMR1, previously found to be the target of autoantibodies in newly diagnosed subjects with lung cancer, is also associated with autoantibodies in sera collected at the pre-symptomatic stage. These findings suggest potential utility of an approach to diagnosis of lung cancer before onset of symptoms that includes screening for autoantibodies to defined antigens, including LAMR1.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/35/55
Under Review
Three
The findings of this study suggest potential utility of an approach to diagnosis of lung cancer before onset of symptoms that includes screening for autoantibodies to defined antigens. Investigation of LAMR1 (RPSA) is ongoing.
0047332af278485096ce50b05280ef2f
no
no
Contents

There are currently no items in this folder.